Early Promise in Drug Trial for Fighting Cholesterol


The latest study of alirocumab, a potentially powerful cholesterol fighter, appears to bolster previous results that it cut cholesterol levels by about half in a clinical trial.

    



Powered by WPeMatico


This entry was posted in Science. Bookmark the permalink.

Comments are closed.